SEC Form 4 · accession 0001104659-15-012637
NPS PHARMACEUTICALS INC · NPSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin D Friedman
Officer — SVP of Human Resources
Period of report
Feb 12, 2015
Accepted (ET)
Feb 20, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Feb 12, 2015 | A | 3,272 | A | — | — | Common Stock | 3,272 | 3,272 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents a contingent right to receive one share of the NPS Pharmaceuticals, Inc.'s common stock.
- F2Restricted Stock Units will vest as follows: (i) one third will vest on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant, and (iii) one third on the third anniversary of date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.